Is screening for gonorrhea and chlamydia cost-effective in reducing the cumulative incidence of these infections in menwho have sex with men taking HIV pre exposure prophylaxis (PrEP): a randomized, multicenter controlled trial

Medicine & Life Sciences

1. Practice Guidelines 100%
2. Contact Tracing 75%
3. Infections 38%
4. Physicians 33%
5. Gonorrhea 32%
6. Multicenter Studies 23%
7. Incidence 12%